Skip to main content
. 2007 Feb 6;96(3):450–456. doi: 10.1038/sj.bjc.6603598

Figure 2.

Figure 2

Effect of 1 mM monoHER and 50 μM zVAD-fmk on cell cycle progression in cardiomyocytes, endothelial cells and ovarian cancer cells treated with 1 μM DOX for 48 h. The percentage of cells in the different cell cycle fractions was determined by flow cytometry.